FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Olivier Micheau

Research Profile

Chemicals & Drugs

Anatomy

Physiology

Procedures

Flow Cytometry

Disorders

Colonic Neoplasms

Co-author Network

Publications

TOP 3
Sarah Shirley; Olivier Micheau
Targeting c-FLIP in cancer.
Guillaume Wettstein; Pierre-Simon Bellaye; Philippe Camus; Bruno Crestani; Carmen Garrido; Jack Gauldie; Martin Gleave; Andreas Gunther; Arlette Hammann; Adonis Hazoume; Martin Kolb; Joëlle Marchal-Somme; Olivier Micheau; Paul Soler; Philippe Bonniaud
Inhibition of HSP27 blocks fibrosis development and EMT features by promoting Snail degradation.
Syam Prakash Somasekharan; Poul H B Sorensen; Olivier Micheau; Alexandre Morizot; Ladislav Andera; Olivier Gaide; Michal Koc; Jean-Claude Martinou
TRAIL promotes membrane blebbing, detachment and migration of cells displaying a dysfunctional intrinsic pathway of apoptosis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Olivier Micheau (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Sarah Shirley; Olivier Micheau
Targeting c-FLIP in cancer.
Cancer letters 2013;332(2):141-50.
2013: Guillaume Wettstein; Pierre-Simon Bellaye; Philippe Camus; Bruno Crestani; Carmen Garrido; Jack Gauldie; Martin Gleave; Andreas Gunther; Arlette Hammann; Adonis Hazoume; Martin Kolb; Joëlle Marchal-Somme; Olivier Micheau; Paul Soler; Philippe Bonniaud
Inhibition of HSP27 blocks fibrosis development and EMT features by promoting Snail degradation.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2013;27(4):1549-60.
2013: Syam Prakash Somasekharan; Poul H B Sorensen; Olivier Micheau; Alexandre Morizot; Ladislav Andera; Olivier Gaide; Michal Koc; Jean-Claude Martinou
TRAIL promotes membrane blebbing, detachment and migration of cells displaying a dysfunctional intrinsic pathway of apoptosis.
Apoptosis : an international journal on programmed cell death 2013;18(3):324-36.
2012: Y Estornes; G Jacquemin; Najoua LALAOUI; M Bonnin; P Mercier-Gouy; Olivier Micheau; Y Pachéco; A Pierrot; Toufic Renno; Bruno Salaun; F Toscano; Béatrice Vanbervliet; F Virard; Serge Lebecque
dsRNA induces apoptosis through an atypical death complex associating TLR3 to caspase-8.
Cell death and differentiation 2012;19(9):1482-94.
2011: Sarah Shirley; Alexandre Morizot; Olivier Micheau
Regulating TRAIL receptor-induced cell death at the membrane : a deadly discussion.
Recent patents on anti-cancer drug discovery 2011;6(3):311-23.
2011: Zineb El Fajoui; Guillaume Jacquemin; Olivier Micheau; Jean-Yves Scoazec; Florent Toscano; Jacques Abello; Jean-Christophe Saurin
Oxaliplatin sensitizes human colon cancer cells to TRAIL through JNK-dependent phosphorylation of Bcl-xL.
Gastroenterology 2011;141(2):663-73.
2011: A Morizot; Delphine Mérino; Najoua LALAOUI; G Jacquemin; Virginie Granci; E Iessi; D Lanneau; F Bouyer; Eric Solary; Bruno Chauffert; Philippe Saas; Carmen Garrido; Olivier Micheau
Chemotherapy overcomes TRAIL-R4-mediated TRAIL resistance at the DISC level.
Cell death and differentiation 2011;18(4):700-11.
2010: Guillaume Jacquemin; Sarah Shirley; Olivier Micheau
Combining naturally occurring polyphenols with TNF-related apoptosis-inducing ligand: a promising approach to kill resistant cancer cells?
Cellular and molecular life sciences : CMLS 2010;67(18):3115-30.
2010: Jennifer Fraszczak; Malika Trad; Nona Janikashvili; Dominique Cathelin; Daniela Lakomy; Virginie Granci; Alexandre Morizot; Sylvain Audia; Olivier Micheau; Laurent Lagrost; Emmanuel Katsanis; Eric Solary; Nicolas Larmonier; Bernard Bonnotte
Peroxynitrite-dependent killing of cancer cells and presentation of released tumor antigens by activated dendritic cells.
Journal of immunology (Baltimore, Md. : 1950) 2010;184(4):1876-84.
2009: Arnaud Jacquel; Naïma Benikhlef; Jérôme Paggetti; Najoua LALAOUI; Leslie Guery; Erick K Dufour; Marion Ciudad; Cindy Racoeur; Olivier Micheau; Laurent Delva; Nathalie M Droin; Eric Solary
Colony-stimulating factor-1-induced oscillations in phosphatidylinositol-3 kinase/AKT are required for caspase activation in monocytes undergoing differentiation into macrophages.
Blood 2009;114(17):3633-41.
2008: Marion Travert; Patricia Ame-Thomas; Céline Pangault; Alexandre Morizot; Olivier Micheau; Gilbert Semana; Thierry Lamy; Thierry Fest; Karin Tarte; Thierry Guillaudeux
CD40 ligand protects from TRAIL-induced apoptosis in follicular lymphomas through NF-kappaB activation and up-regulation of c-FLIP and Bcl-xL.
Journal of immunology (Baltimore, Md. : 1950) 2008;181(2):1001-11.
2007: Delphine Mérino; Najoua LALAOUI; Alexandre Morizot; Eric Solary; Olivier Micheau
TRAIL in cancer therapy: present and future challenges.
Expert opinion on therapeutic targets 2007;11(10):1299-314.
2007: Cédric Rébé; Séverine Cathelin; Sophie Launay; Rodolphe Filomenko; Laurent Prévotat; Coralie L'Ollivier; Emmanuel Gyan; Olivier Micheau; Steven Grant; Anne Dubart Kupperschmitt; Michaëla Fontenay; Eric Solary
Caspase-8 prevents sustained activation of NF-kappaB in monocytes undergoing macrophagic differentiation.
Blood 2007;109(4):1442-50.
2007: Olivier Meurette; Amélie Rebillard; Laurence Huc; Gwenaelle Le Moigne; Delphine Merino; Olivier Micheau; Dominique Lagadic-Gossmann; Marie-Thérèse Dimanche-Boitrel
TRAIL induces receptor-interacting protein 1-dependent and caspase-dependent necrosis-like cell death under acidic extracellular conditions.
Cancer research 2007;67(1):218-26.
2006: Nelly Buron; Olivier Micheau; Séverine Cathelin; Pierre-Olivier Lafontaine; Catherine Creuzot-Garcher; Eric Solary
Differential mechanisms of conjunctival cell death induction by ultraviolet irradiation and benzalkonium chloride.
Investigative ophthalmology & visual science 2006;47(10):4221-30.
2006: Delphine Mérino; Najoua LALAOUI; Alexandre Morizot; Pascal Schneider; Eric Solary; Olivier Micheau
Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2.
Molecular and cellular biology 2006;26(19):7046-55.
2006: Caroline Salon; Béatrice Eymin; Olivier Micheau; Laurence Chaperot; Joël Plumas; Christian Brambilla; Elisabeth Brambilla; Sylvie Gazzeri
E2F1 induces apoptosis and sensitizes human lung adenocarcinoma cells to death-receptor-mediated apoptosis through specific downregulation of c-FLIP(short).
Cell death and differentiation 2006;13(2):260-72.
2006: anthony lemarie; Claudie Morzadec; Delphine Mérino; Olivier Micheau; Olivier Fardel; Laurent Vernhet
Arsenic trioxide induces apoptosis of human monocytes during macrophagic differentiation through nuclear factor-kappaB-related survival pathway down-regulation.
The Journal of pharmacology and experimental therapeutics 2006;316(1):304-14.
2004: Dominique Delmas; Cédric Rébé; Olivier Micheau; Anne Athias; Philippe Gambert; Solène Grazide; Guy Laurent; Norbert Latruffe; Eric Solary
Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells.
Oncogene 2004;23(55):8979-86.
2004: Olivier Micheau; Delphine Mérino
Controlling TRAIL-mediated caspase-3 activation.
Leukemia 2004;18(10):1578-80.
2003: Sandrine Lacour; Olivier Micheau; Arlette Hammann; Véronique Drouineaud; Jurg Tschopp; Eric Solary; Marie-Thérèse Dimanche-Boitrel
Chemotherapy enhances TNF-related apoptosis-inducing ligand DISC assembly in HT29 human colon cancer cells.
Oncogene 2003;22(12):1807-16.
2003: Patrick Ducoroy; Olivier Micheau; Sylvain Perruche; Laurence Dubrez-Daloz; Daniel de Fornel; Patrick Dutartre; Philippe Saas; Eric Solary
LF 15-0195 immunosuppressive agent enhances activation-induced T-cell death by facilitating caspase-8 and caspase-10 activation at the DISC level.
Blood 2003;101(1):194-201.
2000: Marie-Thérèse Dimanche-Boitrel; Olivier Micheau; D France; Arlette Hammann; Olivier Duchamp; Philippe Genne; Eric Solary
P27KiP1 overexpression inhibits the growth and doxorubicin sensitivity of HT29 human colon cancer cells in vivo.
Anticancer research 2000;20(2A):849-52.
1999: Olivier Micheau; Arlette Hammann; Eric Solary; Marie-Thérèse Dimanche-Boitrel
STAT-1-independent upregulation of FADD and procaspase-3 and -8 in cancer cells treated with cytotoxic drugs.
Biochemical and biophysical research communications 1999;256(3):603-7.
1999: Olivier Micheau; Eric Solary; Arlette Hammann; Marie-Thérèse Dimanche-Boitrel
Fas ligand-independent, FADD-mediated activation of the Fas death pathway by anticancer drugs.
The Journal of biological chemistry 1999;274(12):7987-92.
1998: Marie-Thérèse Dimanche-Boitrel; Olivier Micheau; Arlette Hammann; M Haugg; Béatrice Eymin; Bruno Chauffert; Eric Solary
Contribution of the cyclin-dependent kinase inhibitor p27KIP1 to the confluence-dependent resistance of HT29 human colon carcinoma cells.
International journal of cancer. Journal international du cancer 1998;77(5):796-802.
1998: Eric Solary; Olivier Micheau; Marie-Thérèse Dimanche-Boitrel; F Martin
[The Fas/Fas-ligand system: implications in the antitumor immune response and in the activity of cytotoxic agents].
Bulletin du cancer 1998;85(8):685-94.
1998: Bernard Bonnotte; N Favre; S Reveneau; Olivier Micheau; Nathalie M Droin; Carmen Garrido; A Fontana; Bruno Chauffert; Eric Solary; François Martin
Cancer cell sensitization to fas-mediated apoptosis by sodium butyrate.
Cell death and differentiation 1998;5(6):480-7.
1997: Olivier Micheau; Eric Solary; Arlette Hammann; F Martin; Marie-Thérèse Dimanche-Boitrel
Sensitization of cancer cells treated with cytotoxic drugs to fas-mediated cytotoxicity.
Journal of the National Cancer Institute 1997;89(11):783-9.